Chih-Liang Chin, Ph.D.
Affiliations: | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Structural NMR ImagingGoogle:
"Chih-Liang Chin"Mean distance: 22.36 | S | N | B | C | P |
Parents
Sign in to add mentorFelix W. Wehrli | grad student | 2004 | Penn | |
(Indirect detection of biological tissue microstructure by nuclear magnetic resonance microscopy.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Seah S, Asad AB, Baumgartner R, et al. (2014) Investigation of cross-species translatability of pharmacological MRI in awake nonhuman primate - a buprenorphine challenge study. Plos One. 9: e110432 |
Baker S, Chin CL, Basso AM, et al. (2012) Xanomeline modulation of the blood oxygenation level-dependent signal in awake rats: development of pharmacological magnetic resonance imaging as a translatable pharmacodynamic biomarker for central activity and dose selection. The Journal of Pharmacology and Experimental Therapeutics. 341: 263-73 |
Upadhyay J, Baker SJ, Chandran P, et al. (2011) Default-mode-like network activation in awake rodents. Plos One. 6: e27839 |
Zhu CZ, Chin CL, Rustay NR, et al. (2011) Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats. Biochemical Pharmacology. 82: 967-76 |
Sakoğlu U, Upadhyay J, Chin CL, et al. (2011) Paradigm shift in translational neuroimaging of CNS disorders. Biochemical Pharmacology. 81: 1374-87 |
Chin CL, Upadhyay J, Marek GJ, et al. (2011) Awake rat pharmacological magnetic resonance imaging as a translational pharmacodynamic biomarker: metabotropic glutamate 2/3 agonist modulation of ketamine-induced blood oxygenation level dependence signals. The Journal of Pharmacology and Experimental Therapeutics. 336: 709-15 |
Chin CL, Curzon P, Schwartz AJ, et al. (2011) Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia. Synapse (New York, N.Y.). 65: 393-403 |
Chin C, Marek G, Hradil V, et al. (2010) THE MGLUR2/3 AGONIST LY379268 MODULATES KETAMINE-INDUCED BOLD FMRI IN AWAKE RATS: UTILITY AS A PHARMACODYNAMIC BIOMARKER? Schizophrenia Research. 117: 275-276 |
Chin CL, Pai M, Bousquet PF, et al. (2009) Distinct spatiotemporal pattern of CNS lesions revealed by USPIO-enhanced MRI in MOG-induced EAE rats implicates the involvement of spino-olivocerebellar pathways. Journal of Neuroimmunology. 211: 49-55 |
Yao BB, Hsieh G, Daza AV, et al. (2009) Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging. The Journal of Pharmacology and Experimental Therapeutics. 328: 141-51 |